Abstract

Background: Various microorganisms such as bacteria, virus, and fungi can infect humans and cause not just a simple infection but septic conditions, organ dysfunction, and precancerous conditions or cancer involving various organ systems. After the discovery of the microscope, it was easier to discover and study such microorganisms, as in the case of Helicobacter pylori, a pathogen that was seen in the distant era of the nineteenth century but without being recognized as such. It took 100 years to later discover the pathogenesis and the cancer that this bacterium can cause. Since it was discovered, until today, there has been a continuous search for the understanding of its pathogenetic mechanisms, and the therapeutic approach is continuously updated. Methods: We investigated how diagnosis and therapy were dealt with in the past and how researchers sought to understand, exactly, the pathogenetic biomolecular mechanisms of H. pylori, from the genesis of the infection to the current knowledge, with an analysis of carcinogenic mechanisms in the stomach. We have examined the scientific evolution of the knowledge of the disease over these 40 years in the gastroenterological and pharmacological fields. This was possible through a search in the databases of Medline, the WHO website, the Centers for Disease Control and Prevention (CDC) website, PubMed, and Web of Science to analyze the earlier and the latest data regarding H. pylori. Results: With the scientific discoveries over time, thanks to an increasing number of progressions in scientific research in the analysis of the gastric mucosa, the role of Helicobacter pylori in peptic ulcer, carcinogenesis, and in some forms of gastric lymphoma was revealed. Furthermore, over the years, the biomolecular mechanism involvement in some diseases has also been noted (such as cardiovascular ones), which could affect patients positive for H. pylori. Conclusions: Thanks to scientific and technological advances, the role of the bacterium H. pylori in carcinogenesis has been discovered and demonstrated, and new prospective research is currently attempting to investigate the role of other factors in the stomach and other organs. Cancer from H. pylori infection had a high incidence rate compared to various types of cancer, but in recent years, it is improving thanks to the techniques developed in the detection of the bacterium and the evolution of therapies. Thus, although it has become an increasingly treatable disease, there is still continuous ongoing research in the field of treatment for resistance and pharma compliance. Furthermore, in this field, probiotic therapy is considered a valid adjuvant.

Highlights

  • IntroductionHelicobacter pylori is a Gram-negative bacterium, microaerophilic (requires O2 at a lower concentration than in the atmosphere: 5% O2 , 15% CO2 , and 80% N), has a helical shape, and is categorized as a curved rod not spirochaete bacterium (3 μm long, diameter about 0.5 μm) that usually colonizes the gastric mucosa [1]

  • Introduction distributed under the terms and Helicobacter pylori is a Gram-negative bacterium, microaerophilic, has a helical shape, and is categorized as a curved rod not spirochaete bacterium (3 μm long, diameter about 0.5 μm) that usually colonizes the gastric mucosa [1]

  • Epidemiological studies conducted in recent years have revealed that H. pylori infection represents an endemic disease all over the world

Read more

Summary

Introduction

Helicobacter pylori is a Gram-negative bacterium, microaerophilic (requires O2 at a lower concentration than in the atmosphere: 5% O2 , 15% CO2 , and 80% N), has a helical shape, and is categorized as a curved rod not spirochaete bacterium (3 μm long, diameter about 0.5 μm) that usually colonizes the gastric mucosa [1]. From bacillary to coccoid form (a survival form) [2] and can form organized bacterial surface colonies (bio-membranes). In its spiral form, it can survive for at least a week in water, and in the coccoid form, probably for much longer periods. The outer layer of the membrane is made up of phospholipids and lipopolysaccharides (LPS) and cholesterol glycosides (which are present in a few other Gram-negative bacteria). H. pylori consists of a wide diversity of strains and genomes that have been completely sequenced.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call